首页> 外文期刊>Microbial Cell Factories >Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways
【24h】

Whole-genome and enzymatic analyses of an androstenedione-producing Mycobacterium strain with residual phytosterol-degrading pathways

机译:一种雄甾酮生成分枝杆菌菌株的全基因组和酶促分析,残留植物甾醇降解途径

获取原文
           

摘要

Mycobacterium neoaurum strains can transform phytosterols to 4-androstene-3,17-dione (4-AD), a key intermediate for the synthesis of advanced steroidal medicines. In this work, we presented the complete genome sequence of the M. neoaurum strain HGMS2, which transforms β-sitosterol to 4-AD. Through genome annotation, a phytosterol-degrading pathway in HGMS2 was predicted and further shown to form a 9,10-secosteroid intermediate by five groups of enzymes. These five groups of enzymes included three cholesterol oxidases (ChoM; group 1: ChoM1, ChoM2 and Hsd), two monooxygenases (Mon; group 2: Mon164 and Mon197), a set of enzymes for side-chain degradation (group 3), one 3-ketosteroid-1,2-dehydrogenase (KstD; group 4: KstD211) and three 3-ketosteroid-9a-hydroxylases (Ksh; group 5: KshA226, KshA395 and KshB122). A gene cluster encoding Mon164, KstD211, KshA226, KshB122 and fatty acid β-oxidoreductases constituted one integrated metabolic pathway, while genes encoding other key enzymes were sporadically distributed. All key enzymes except those from group 3 were prepared as recombinant proteins and their activities were evaluated, and the proteins exhibited distinct activities compared with enzymes identified from other bacterial species. Importantly, we found that the KstD211 and KshA395 enzymes in the HGMS2 strain retained weak activities and caused the occurrence of two major impurities, i.e., 1,4-androstene-3,17-dione (ADD) and 9-hydroxyl-4-androstene-3,17-dione (9OH-AD) during β-sitosterol fermentation. The concurrence of these two 4-AD analogs not only lowered 4-AD production yield but also hampered 4-AD purification. HGMS2 has the least number of genes encoding KstD and Ksh enzymes compared with current industrial strains. Therefore, HGMS2 could be a potent strain by which the 4-AD production yield could be enhanced by disabling the KstD211 and KshA395 enzymes. Our work also provides new insight into the engineering of the HGMS2 strain to produce ADD and 9OH-AD for industrial application.
机译:分枝杆菌菌株可以将植物甾醇转化为4- androstene-3,17-dione(4-AD),是用于合成晚期甾体药物的关键中间体。在这项工作中,我们介绍了M. neoaurum菌株HGMS2的完整基因组序列,其将β-纬度溶胶转化为4-AD。通过基因组注释,预测HGMS2中的植物甾醇降解途径,并进一步示出了通过五组酶形成9,10-秒甾醇中间体。这五组酶包括三种胆固醇氧化酶(CHOM;第1组:CHOM1,CHOM2和HSD),两种单氧基酶(MON;第2组:MON164和MON197),一组用于侧链降解(第3组),一个酶3-酮酮-1,2-脱氢酶(KSTD;第4组:KSTD211)和三种3-酮类固醇-9A-羟基酶(KSH;第5组:KSHA226,KSHA395和KSHB122)。编码MON164,KSTD211,KSHA226,KSHB122和脂肪酸β-氧化还原酶的基因簇构成了一种综合代谢途径,而编码其他关键酶的基因均散布地分布。除了来自第3组的所有关键酶被制备为重组蛋白质,并评估其活性,与其他细菌种类鉴定的酶相比,蛋白质表现出不同的活性。重要的是,我们发现HGMS2菌株中的KSTD211和KSHA395酶保留了弱活性,并导致发生两个主要杂质,即1,4-甲甾烷酮-3,17-二酮(加入)和9-羟基-4-羟丙烯β-谷甾醇发酵期间-3,17-二酮(9OH-AD)。这两个4-AD类似物的同意不仅降低了4-AD产量,而且阻碍了4-AD净化。 HGMS2具有编码KSTD和KSH酶的最少数量的基因与当前的工业菌株相比。因此,HGMS2可以是有效的应变,通过禁用KSTD211和KSHA395酶可以提高4-AD产生产率。我们的工作还提供了对HGMS2菌株的工程进行了新的洞察力,以生产加入和90年代的工业应用。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号